Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC). Study Research Group- Intensive Diabetes Treatment and Cardiovascular outcomes in Type 1 diabetes: the DCCT/EDIC Study 30-Year follow-up. Diabetes Care. 2016;39(5):686–93.

Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972–82.

Article  PubMed  Google Scholar 

Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia. 2007;50(11):2239–44.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nathan DM, Cleary PA, Backlund J-YC, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.

Article  PubMed  Google Scholar 

Bergenstal RM, Beck WY, Close KL, et al. Glucose Management Indicator (GMI): a New term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41:2275–80.

Article  PubMed  PubMed Central  Google Scholar 

Hempe JM, Yang S, Liu S, et al. Standardizing the haemoglobin glycation index. Endocrinol Diabetes Metab. 2021;4(4):e00299.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Goh S-Y, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008;93(4):1143–52.

Article  PubMed  CAS  Google Scholar 

Osawa S, Katakami N, Kuroda A, et al. Skin autofluorescence is associated with early-stage atherosclerosis in patients with type 1 diabetes. J Atheroscler Thromb. 2017;24:312–26.

Article  PubMed  PubMed Central  Google Scholar 

Bansal S, Burman A, Tripathi AK. Advanced glycation end products: key mediator and therapeutic target of cardiovascular complications in diabetes. World J Diabetes. 2023;14(8):1146–62.

Article  PubMed  PubMed Central  Google Scholar 

De la Cruz-Ares S, Cardelo MP, Gutiérrez-Mariscal FM, et al. Endothelial dysfunction and advanced glycation end products in patients with newly diagnosed versus established diabetes: from the CORDIOPREV Study. Nutrients. 2020;12(1):238.

Article  PubMed  PubMed Central  Google Scholar 

Ninomiya H, Katakami N, Sato I, et al. Association between subclinical atherosclerosis markers and the level of accumulated advanced glycation end-products in the skin of patients with diabetes. J Atheroscler Thromb. 2018;25(12):1274–84.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Soedamah-Muthu ss, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia. 2006;49(4):660–6.

Article  PubMed  CAS  Google Scholar 

Colom C, Rull A, Sanchez-Quesada JL, Pérez A. Cardiovascular disease in type 1 diabetes mellitus: epidemiology and management of cardiovascular risk. J Clin Med. 2021;10(8):1798.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–67.

Article  PubMed  Google Scholar 

Viñals C, Conget I, Granados M, Giménez M, Amor AJ. Evaluation of cardiovascular risk in people with type 1 diabetes: a comprehensive and specific proposed practical approach. Diabetes Ther. 2024;15(8):1831–44.

Article  PubMed  PubMed Central  Google Scholar 

Serés-Noriega T, Perea V, Amor AJ. Screening for subclinical atherosclerosis and the prediction of cardiovascular events in people with type 1 diabetes. J Clin Med. 2024;13(4):1097.

Article  PubMed  PubMed Central  Google Scholar 

Boswell L, Serés-Noriega T, Alex Mesa A, et al. Carotid ultrasonography as a strategy to optimize cardiovascular risk management in type 1 diabetes: a cohort study. Acta Diabetol. 2022;59(12):1563–74.

Article  PubMed  CAS  Google Scholar 

Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.

Article  PubMed  Google Scholar 

Mancia G, Kreutz R, Brunström M, et al. 2023 ESH guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071.

Article  PubMed  CAS  Google Scholar 

Danne T, Nimri R, Battelino T, et al. International Consensus on Use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631–40.

Article  PubMed  PubMed Central  Google Scholar 

Maran A, Morieri ML, Falaguasta D, Avogaro A, Fadini GP. The fast-glycator phenotype, skin advanced glycation end products, and complication Burden among people with type 1 diabetes. Diabetes Care. 2022;45(10):2439–44.

Article  PubMed  CAS  Google Scholar 

Amor AJ, Catalan M, Pérez A, et al. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis. Atherosclerosis. 2016;247:161–9.

Article  PubMed  CAS  Google Scholar 

Touboul P-J, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European stroke conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290–6.

Perlman JE, Gooley TA, McNulty B, Meyers J, Hirsc IB. HbA1c and glucose management indicator discordance: a real-world analysis. Diabetes Technol Ther. 2021;23(4):253–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Grimsmann JM, Sengbusch SV, Freff M, et al. Glucose management indicator based on sensor data and laboratory HbA1c in people with type 1 diabetes from the DPV database: differences by Sensor Type. Diabetes Care. 2020;43(9):e111–2.

Article  PubMed  CAS  Google Scholar 

Piona C, Marigliano M, Mozzillo E, et al. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2022;23(1):84–9.

Article  PubMed  CAS  Google Scholar 

Oriot P, Viry C, Vandelaer A, et al. Discordance between glycated hemoglobin A1c and the glucose management Indicator in people with diabetes and chronic kidney disease. J Diabetes Sci Technol. 2023;17(6):1553–62.

Article  PubMed  CAS  Google Scholar 

Sakane N, Hirota Y, Yamamoto A, et al. Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: the FGM-Japan study. J Diabetes Investig. 2023;14(4):582–90.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dunn TC, Xu Y, Bergenstal RM, Ogawa W, Ajjan RA. Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator. Diabetes Technol Ther. 2023;25(S3):S65–74.

Article  PubMed  Google Scholar 

Shah VN, Vigers T, Pyle L, Calhoun P, Bergenstal RM. Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. Diabetes Technol Ther. 2023;25(5):324–8.

Article  PubMed  CAS  Google Scholar 

Stimson RH, Dover AR, Forbes S, Strachan MWJ, McKnight JA, Gibb FW. HbA1c is disproportionately higher in women and older people with type 1 diabetes compared with flash glucose monitoring metrics of glycemic control. J Diabetes Sci Technol. 2022;16(2):446–53.

Article  PubMed  CAS  Google Scholar 

Ibarra-Salce R, Pozos-Varela FJ, Martinez-Zavala N, et al. Correlation between hemoglobin glycation index measured by continuous glucose monitoring with complications in type 1 diabetes. Endocr Pract. 2023;29(3):162–7.

Article